/
Other
Testosterone
10
Pipeline Programs↗
12
Active Trials↗
19
Companies Involved↗
Testosterone is an early-stage landscape with 10 programs across 19 companies. The most active players are Merck & Co..
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
Phase 1
No programs
Phase 27
Phase 3
No programs
Approved
No programs
Analysis
Trial Status
165
clinical trials
Completed119 · 72%
Unknown status12 · 7%
Terminated11 · 7%
Withdrawn11 · 7%
Not yet recruiting5 · 3%
Recruiting4 · 2%
Other3 · 2%
Clinical Trials
Trial Activity
165 trials
Supraphysiologic Testosterone Priming Induces Darolutamide Extended Response
Recruiting·SSidney Kimmel Comprehensive Cancer Center at Johns Hopkins·Phase 2·NCT07142551·60 enrolled
Page 1 of 11
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)